Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations of guanylate cyclase C agonists and methods of use

Formulations of guanylate cyclase C agonists and methods of use

US Patent 9925231 · Granted Mar 27, 2018

Estimated economic value: $7,003,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ultra-pure agonists of guanylate cyclase C, method of making and using same2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same2024
Dactinomycin compositions and methods for the treatment of myelodysplastic syndr2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same2021
Ultra-pure agonists of guanylate cyclase C, method of making and using same2021